948 related articles for article (PubMed ID: 26982367)
41. Fas ligand and tumour counter-attack in colorectal cancer stratified according to microsatellite instability status.
Michael-Robinson JM; Pandeya N; Cummings MC; Walsh MD; Young JP; Leggett BA; Purdie DM; Jass JR; Radford-Smith GL
J Pathol; 2003 Sep; 201(1):46-54. PubMed ID: 12950016
[TBL] [Abstract][Full Text] [Related]
42. Microsatellite instability testing and its role in the management of colorectal cancer.
Kawakami H; Zaanan A; Sinicrope FA
Curr Treat Options Oncol; 2015 Jul; 16(7):30. PubMed ID: 26031544
[TBL] [Abstract][Full Text] [Related]
43. Clinical effects of adjuvant active specific immunotherapy differ between patients with microsatellite-stable and microsatellite-instable colon cancer.
de Weger VA; Turksma AW; Voorham QJ; Euler Z; Bril H; van den Eertwegh AJ; Bloemena E; Pinedo HM; Vermorken JB; van Tinteren H; Meijer GA; Hooijberg E
Clin Cancer Res; 2012 Feb; 18(3):882-9. PubMed ID: 22156611
[TBL] [Abstract][Full Text] [Related]
44. Distinctive patterns of p53 protein expression and microsatellite instability in human colorectal cancer.
Nyiraneza C; Jouret-Mourin A; Kartheuser A; Camby P; Plomteux O; Detry R; Dahan K; Sempoux C
Hum Pathol; 2011 Dec; 42(12):1897-910. PubMed ID: 21665242
[TBL] [Abstract][Full Text] [Related]
45. LOH and copy neutral LOH (cnLOH) act as alternative mechanism in sporadic colorectal cancers with chromosomal and microsatellite instability.
Melcher R; Hartmann E; Zopf W; Herterich S; Wilke P; Müller L; Rosler E; Kudlich T; Al-Taie O; Rosenwald A; Katzenberger T; Scholtka B; Seibold S; Rogoll D; Scheppach W; Scheurlen M; Lührs H
Carcinogenesis; 2011 Apr; 32(4):636-42. PubMed ID: 21297112
[TBL] [Abstract][Full Text] [Related]
46. Microsatellite instability and novel mismatch repair gene mutations in northern Chinese population with hereditary non-polyposis colorectal cancer.
Sheng JQ; Chan TL; Chan YW; Huang JS; Chen JG; Zhang MZ; Guo XL; Mu H; Chan AS; Li SR; Yuen ST; Leung SY
Chin J Dig Dis; 2006; 7(4):197-205. PubMed ID: 17054581
[TBL] [Abstract][Full Text] [Related]
47. Correlations between microsatellite instability and the biological behaviour of tumours.
Yang G; Zheng RY; Jin ZS
J Cancer Res Clin Oncol; 2019 Dec; 145(12):2891-2899. PubMed ID: 31617076
[TBL] [Abstract][Full Text] [Related]
48. Low level microsatellite instability may be associated with reduced cancer specific survival in sporadic stage C colorectal carcinoma.
Wright CM; Dent OF; Newland RC; Barker M; Chapuis PH; Bokey EL; Young JP; Leggett BA; Jass JR; Macdonald GA
Gut; 2005 Jan; 54(1):103-8. PubMed ID: 15591513
[TBL] [Abstract][Full Text] [Related]
49. Prognostic value of BRAF and KRAS mutation status in stage II and III microsatellite instable colon cancers.
de Cuba EM; Snaebjornsson P; Heideman DA; van Grieken NC; Bosch LJ; Fijneman RJ; Belt E; Bril H; Stockmann HB; Hooijberg E; Punt CJ; Koopman M; Nagtegaal ID; Coupé VH; Carvalho B; Meijer GA
Int J Cancer; 2016 Mar; 138(5):1139-45. PubMed ID: 26376292
[TBL] [Abstract][Full Text] [Related]
50. Transcriptional profiles underpin microsatellite status and associated features in colon cancer.
Hogan J; DeJulius K; Liu X; Coffey JC; Kalady MF
Gene; 2015 Oct; 570(1):36-43. PubMed ID: 25704535
[TBL] [Abstract][Full Text] [Related]
51. T cell-inflamed gene expression profile is associated with favorable disease-specific survival in non-hypermutated microsatellite-stable colorectal cancer patients.
Yin H; Harrison TA; Thomas SS; Sather CL; Koehne AL; Malen RC; Reedy AM; Wurscher MA; Hsu L; Phipps AI; Zaidi SHE; Newcomb PA; Peters U; Huyghe JR
Cancer Med; 2023 Mar; 12(6):6583-6593. PubMed ID: 36341526
[TBL] [Abstract][Full Text] [Related]
52. Gene expression profiles of CMS2-epithelial/canonical colorectal cancers are largely driven by DNA copy number gains.
Berg KCG; Sveen A; Høland M; Alagaratnam S; Berg M; Danielsen SA; Nesbakken A; Søreide K; Lothe RA
Oncogene; 2019 Aug; 38(33):6109-6122. PubMed ID: 31308487
[TBL] [Abstract][Full Text] [Related]
53. Combined prognostic effect of PD-L1 expression and immunoscore in microsatellite-unstable advanced gastric cancers.
Kim KJ; Yang HK; Kim WH; Kang GH
Oncotarget; 2017 Aug; 8(35):58887-58902. PubMed ID: 28938605
[TBL] [Abstract][Full Text] [Related]
54. The density of Tbet+ tumor-infiltrating T lymphocytes reflects an effective and druggable preexisting adaptive antitumor immune response in colorectal cancer, irrespective of the microsatellite status.
Ott E; Bilonda L; Dansette D; Deleine C; Duchalais E; Podevin J; Volteau C; Bennouna J; Touchefeu Y; Fourquier P; El Alami Thomas W; Chetritt J; Bezieau S; Denis M; Toquet C; Mosnier JF; Jarry A; Bossard C
Oncoimmunology; 2019; 8(4):e1562834. PubMed ID: 30906656
[No Abstract] [Full Text] [Related]
55. [Focus on the Immunoscore and its potential clinical implications].
El Sissy C; Marliot F; Haicheur N; Kirilovsky A; Scripcariu D; Lagorce-Pagès C; Galon J; Pagès F
Ann Pathol; 2017 Feb; 37(1):29-38. PubMed ID: 28161000
[TBL] [Abstract][Full Text] [Related]
56. [Role of immunotherapy in the management of colorectal cancer].
Bodoky G
Magy Onkol; 2017 Jun; 61(2):147-151. PubMed ID: 28585616
[TBL] [Abstract][Full Text] [Related]
57. The microsatellite instable subset of colorectal cancer is a particularly good candidate for checkpoint blockade immunotherapy.
Xiao Y; Freeman GJ
Cancer Discov; 2015 Jan; 5(1):16-8. PubMed ID: 25583798
[TBL] [Abstract][Full Text] [Related]
58. Multicenter International Study of the Consensus Immunoscore for the Prediction of Relapse and Survival in Early-Stage Colon Cancer.
Mlecnik B; Lugli A; Bindea G; Marliot F; Bifulco C; Lee JJ; Zlobec I; Rau TT; Berger MD; Nagtegaal ID; Vink-Börger E; Hartmann A; Geppert CI; Kolwelter J; Merkel S; Grützmann R; Van den Eynde M; Jouret-Mourin A; Kartheuser A; Léonard D; Remue C; Wang J; Bavi P; Roehrl MHA; Ohashi PS; Nguyen LT; Han S; MacGregor HL; Hafezi-Bakhtiari S; Wouters BG; Masucci GV; Andersson EK; Zavadova E; Vocka M; Spacek J; Petruzelka L; Konopasek B; Dundr P; Skalova H; Nemejcova K; Botti G; Tatangelo F; Delrio P; Ciliberto G; Maio M; Laghi L; Grizzi F; Fredriksen T; Buttard B; Lafontaine L; Maby P; Majdi A; Hijazi A; El Sissy C; Kirilovsky A; Berger A; Lagorce C; Paustian C; Ballesteros-Merino C; Dijkstra J; van de Water C; Vliet SVL; Knijn N; Mușină AM; Scripcariu DV; Popivanova B; Xu M; Fujita T; Hazama S; Suzuki N; Nagano H; Okuno K; Torigoe T; Sato N; Furuhata T; Takemasa I; Patel P; Vora HH; Shah B; Patel JB; Rajvik KN; Pandya SJ; Shukla SN; Wang Y; Zhang G; Kawakami Y; Marincola FM; Ascierto PA; Fox BA; Pagès F; Galon J
Cancers (Basel); 2023 Jan; 15(2):. PubMed ID: 36672367
[TBL] [Abstract][Full Text] [Related]
59. Immunoscore
Blair HA
Mol Diagn Ther; 2020 Jun; 24(3):365-370. PubMed ID: 32232741
[TBL] [Abstract][Full Text] [Related]
60. Immunogenomics of Colorectal Tumors: Facts and Hypotheses on an Evolving Saga.
Catalano I; Grassi E; Bertotti A; Trusolino L
Trends Cancer; 2019 Dec; 5(12):779-788. PubMed ID: 31813455
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
